Caspofungin. a new antimycotic agents from the echinocandin group
Hennemann, A.
Medizinische Monatsschrift für Pharmazeuten 24(9): 282-284
2001
ISSN/ISBN: 0342-9601 PMID: 11584760 Document Number: 526485
Document emailed within 1 workday
Related Documents
Schäfer-Korting, M. 1991: Antimycotic agents. Progress in treatment of mycoses Medizinische Monatsschrift für Pharmazeuten 14(7): 197-205Scherwitz, C.; Meinhof, W. 1974: Antimycotic agents for external treatment of dermatomycoses Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 25(10): 463-470
Neubert, R.H.H.; Gensbügel, C.; Jäckel, A.; Wartewig, S. 2006: Different physicochemical properties of antimycotic agents are relevant for penetration into and through human nails Die Pharmazie 61(7): 604-607
León, G.; Mosca, W.; Arguello, A. 1988: In vitro evaluation of the trypanocidal activity of 3 antimycotic agents on fresh plasma infected with T. cruzi Acta Cientifica Venezolana 39(4): 344-348
Lazo de la Vega, S.; Volkow, P.; Yeates, R.A.; Pfaff, G. 1994: Administration of the antimycotic agents fluconazole and itraconazole to leukaemia patients: a comparative pharmacokinetic study Drugs under Experimental and Clinical Research 20(2): 69-75
Ogunshe, A.A.O.; Omotoso, O.A.; Akindele, T.M. 2011: Soaps and germicides as adjunct topical antimycotic agents on candida species implicated in vulvovaginal candidasis East African Journal of Public Health 8(2): 112-118
Qadripur, S.A. 1983: Antimycotic therapy. 3: Polyene antimycotic antibiotics, antimycotic antibiotics without polyene structure Fortschritte der Medizin 101(11): 465-469
Lumholtz, I.B. 1977: Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1 Sygeplejersken 77(16): 13
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Temesgen, Z.; Barreto, J.; Vento, S. 2009: Micafungin - the newest echinocandin Drugs of Today 45(6): 469-478
2002: First echinocandin on the market. New type of antifungal against Aspergillus & Co MMW Fortschritte der Medizin 144 Suppl. 1: 83-84
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924
Furuta, T.; Muramatsu, H.; Fujie, A.; Fujihira, S.; Abudullah, N.R.; Kojima, S. 1998: Therapeutic effects of water-soluble echinocandin compounds on Pneumocystis pneumonia in mice Antimicrobial Agents and ChemoTherapy 42(1): 37-39
Lumholtz, I.B. 1980: Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 10th and last part. 4. other angina pectoris agents Sygeplejersken 80(20): 23
Tsiouris, M.; Ulmer, M.; Yurcho, J.F.; Hooper, K.L.; Gui, M. 2010: Stability and compatibility of reconstituted caspofungin in select elastomeric infusion devices International Journal of Pharmaceutical Compounding 14(5): 436-439
Tunger, O.; Bayram, H.; Degerli, K.; Dinc, G.; Cetin, B.C. 2008: Comparison of the efficacy of combination and monotherapy with caspofungin and liposomal amphotericin B against invasive candidiasis Saudi Medical Journal 29(5): 728-733
Serefko, A.; Los, R.; Biernasiuk, A.; Malm, A. 2008: Comparison of microdilution method and E-test procedure in susceptibility testing of caspofungin against Candida non-albicans species New Microbiologica 31(2): 257-262
Cantón, E.; Pemán, J.; Romero, M.; Valentín, A.; Gobernado, M. 2007: The fungicidal activity and paradoxical effect of caspofungin against yeast. Influence of culture medium and incubation time Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 20(4): 433-441
Igari, J.; Watanabe, N.; Uehara, N.; Inoue, M.; Yoshida, H.; Imafuku, Y.; Nishino, T.; Shibano, T.; Satou, S.; Kobayashi, I.; Takahashi, A.; Yomoda, S.; Matsuoka, K.; Oguri, T.; Ohba, Y.; Kumasaka, K.; Tokuda, K.; Kobayashi, Y.; Hongo, T.; Okada, J.; Sasaki, T.; Matsumoto, N.; Hirata, Y.; Nakasaki, N.; Ono, J.; Takata, T.; Kawaguchi, R.; Ohtaki, Y.; Kajimura, K.; Ishigo, S.; Hashimoto, T.; Aoki, N.; Okamoto, E.; Murakami, E.; Saeki, H. 2000: Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents Japanese Journal of Antibiotics 53(3): 157-170